318 results on '"G. Rosiello"'
Search Results
2. Is surgical skill related to surgical discipline? Results of the PROVESA trial
3. Robot-assisted laparoscopic ureteroureterostomy for injury of an complet ectopic duplicated ureter following robotic radical prostatectomy
4. Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches
5. The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials
6. Are men with low risk prostate cancer but high pirads score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
7. Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?
8. Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series
9. Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? development and external validation of a novel T-stage classification based on clinical and MRI findings
10. Comparison between small renal masses 0–2cm vs. 2.1–4 cm in size: a population-based study
11. Prognostic differences in patients with T1a renal cell carcinoma according to clinical size
12. Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach
13. The current role of renal tumour biopsy in the management of patients with suspected renal cancer: a prospective observational study
14. The iron study: investigation of robot-assisted versus open nephron-sparing surgery
15. Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function
16. Pathological features and predictors of oncologic outcomes in patients with small renal masses
17. Oncologic outcomes after robot-assisted partial nephrectomy in the iron study: results from a large, global, multicentric analysis of patients with clinically localized kidney cancer
18. The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy
19. Prognostic differences and survival outcomes in patients with papillary renal cell carcinoma subtypes – a comparison between type I VS. type II
20. Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes?
21. Changing patterns and predictors of salvage radiation therapy use over time in patients treated for post-prostatectomy biochemical recurrence: a trend analysis over a 20-year period from a multi institutional series
22. Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data
23. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance. results from a single institution series
24. Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
25. A prospective, randomized, phase 3 trial assessing the impact of Early Dorsal Venous Complex (EDVC) ligation on urinary continence recovery after robot-assisted radical prostatectomy. results of an interim analysis on early post-operative outcomes
26. The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study
27. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database
28. Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach
29. The impact of ischemia on chronic kidney disease progression after robotic partial nephrectomy in patients over 75 years old: Results of a multi-institutional collaborative series (ROSULA)
30. The effect of age on cancer-specific mortality in patients with prostate cancer: A population-based study across all stages
31. Concordance of pathologic outcomes in patients with synchronous bilateral renal masses elected for surgical treatment: Implications for preoperative renal biopsy
32. Synchronous metastases rates in T1 renal cell carcinoma: A SEER-based study
33. Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
34. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance: Results from a single institution series
35. When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of morbidity and life expectancy
36. Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches
37. Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? Development and external validation of a novel T-stage classification based on clinical and MRI findings
38. Oncologic outcomes after robot-assisted partial nephrectomy in the IRON study: Results from a large, global, multicentric analysis of patients with clinically localized kidney cancer
39. Distribution of histological subtypes and tumor grade according to tumor size in T1-T2 surgically treated renal cell carcinoma
40. Chronic kidney disease at the time of surgery for renal cancer: How and when is it possible to improve from the baseline renal function? Results from a single tertiary care referral centre
41. Hypertension and cardiovascular morbidity following radical nephrectomy are only sustained by renal parenchyma loss and cardiovascular morbidity
42. The implementation of a prospective standardized postoperative complication system according to the EAU guidelines is associated with a decrease in the rate of adverse postoperative outcomes over time
43. A prospective, randomized, multi-centre trial on the efficiency and effectiveness of proficiency based progression robotic surgical skills training
44. Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial
45. Exploring the effect of metastasis directed therapy on progression patterns of patients with positive 68Ga-PSMA PET/CT and biochemical recurrence from prostate cancer
46. Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience
47. Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?
48. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
49. Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma
50. Surgery or Frailty: Who is the master in eGFR decline after renal surgery in living donor and renal cancer patients?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.